Overview
Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
Background
Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
Indication
Iohexol ia used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/11/29 | Phase 4 | Recruiting | |||
2024/06/05 | Phase 4 | Recruiting | |||
2024/01/23 | Early Phase 1 | Recruiting | Alison Stopeck | ||
2023/08/01 | Phase 4 | Recruiting | Jung Im Jung | ||
2023/07/05 | Not Applicable | Recruiting | Erasme University Hospital | ||
2023/03/06 | Early Phase 1 | Recruiting | |||
2022/11/14 | Phase 1 | Completed | |||
2022/10/14 | Phase 1 | Withdrawn | |||
2022/09/07 | N/A | ENROLLING_BY_INVITATION | |||
2022/07/05 | N/A | Recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| GE Healthcare Inc. | 0407-1414 | INTRAVENOUS, INTRAVASCULAR, ORAL, RECTAL | 350 mg in 1 mL | 4/25/2023 | |
| GE Healthcare Inc. | 0407-1414 | ORAL, INTRAVASCULAR, INTRAVENOUS | 350 mg in 1 mL | 2/1/2024 | |
| GE Healthcare | 0407-1413 | INTRAVENOUS | 300 mg in 1 mL | 4/30/2023 | |
| GE Healthcare | 0407-1414 | INTRAVENOUS | 350 mg in 1 mL | 4/25/2023 | |
| GE Healthcare Inc. | 0407-1412 | INTRATHECAL, INTRAVASCULAR, INTRAVENOUS, ORAL | 240 mg in 1 mL | 2/1/2024 | |
| GE Healthcare Inc. | 0407-1413 | INTRAVENOUS, INTRAVASCULAR, INTRATHECAL, ORAL, RECTAL | 300 mg in 1 mL | 5/8/2023 | |
| GE Healthcare | 0407-1413 | INTRAVENOUS | 300 mg in 1 mL | 4/25/2023 | |
| GE Healthcare | 0407-1414 | INTRAVENOUS | 350 mg in 1 mL | 4/30/2023 | |
| GE Healthcare Inc. | 0407-1413 | INTRAVENOUS, INTRAVASCULAR, INTRATHECAL, ORAL, RECTAL | 300 mg in 1 mL | 4/25/2023 | |
| Interpharma Praha, a.s. | 54702-501 | ORAL | 4.5 g in 1 1 | 1/5/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| OMNIPAQUE INJECTION 350 mg I/ml | SIN05923P | INJECTION | 350 mg/ml | 5/17/1991 | |
| OMNIPAQUE INJECTION 300 mg I/ml | SIN05924P | INJECTION | 300 mg/ml | 5/17/1991 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Iohexol Injection | 国药准字H10980321 | 化学药品 | 注射剂 | 12/11/2019 | |
| Iohexol Injection | 国药准字H20253736 | 化学药品 | 注射剂 | 3/25/2025 | |
| Iohexol Injection | 国药准字H20253738 | 化学药品 | 注射剂 | 3/25/2025 | |
| Iohexol Injection | 国药准字H20253737 | 化学药品 | 注射剂 | 3/25/2025 | |
| Iohexol Injection | 国药准字H20000598 | 化学药品 | 注射剂 | 2/23/2024 | |
| Iohexol Injection | 国药准字H20083565 | 化学药品 | 注射剂 | 3/5/2020 | |
| Iohexol Injection | 国药准字H20000551 | 化学药品 | 注射剂 | 5/22/2020 | |
| Iohexol Injection | 国药准字H19980218 | 化学药品 | 注射剂 | 9/21/2020 | |
| Iohexol Injection | 国药准字HJ20160024 | 化学药品 | 注射剂 | 10/30/2020 | |
| Iohexol Injection | 国药准字H20000591 | 化学药品 | 注射剂 | 2/23/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Omnipaque 180 5.82g/15mL injection vial | 48215 | Medicine | A | 3/9/1994 | |
| Omnipaque 350 94.375g/125mL Injection Bottle | 48234 | Medicine | A | 3/15/1994 | |
| Omnipaque 300 48.525g/75mL Injection Bottle | 48243 | Medicine | A | 3/15/1994 | |
| Omnipaque 350 151g/200mL Injection Bottle | 48241 | Medicine | A | 3/15/1994 | |
| Omnipaque 350 75.5g/100mL Injection Bottle | 48233 | Medicine | A | 3/15/1994 | |
| OMNIPAQUE 240 iohexol 25.9g/50mL injection bottle | 39861 | Medicine | A | 12/10/1992 | |
| Omnipaque 350 15.1g/20mL Injection Vial | 39868 | Medicine | A | 12/10/1992 | |
| OMNIPAQUE 300 iohexol 323.5 g/500 mL solution for injection bottle | 348754 | Medicine | A | 11/10/2021 | |
| Omnipaque 350 56.625g/75mL Injection Bottle | 48225 | Medicine | A | 3/15/1994 | |
| Omnipaque 300 iohexol 32.35g/50mL Injection | 76068 | Medicine | A | 10/31/2000 |